Levosalbutamol
- Generic Name
- Levosalbutamol
- Brand Names
- Xopenex
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 34391-04-3
- Unique Ingredient Identifier
- EDN2NBH5SS
- Background
Levosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
...
- Indication
Indicated for the management of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma.
- Associated Conditions
- Bronchospasm
- Associated Therapies
- -
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2021-12-30
- Lead Sponsor
- University of Aleppo
- Target Recruit Count
- 30
- Registration Number
- NCT05173584
- Locations
- 🇸🇾
Aleppo University Hospital, Aleppo, Aleppo Provice, Syrian Arab Republic
Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 24
- Registration Number
- NCT02802111
Aerosolized Beta-Agonist Isomers in Asthma
- Conditions
- Interventions
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Duke University
- Target Recruit Count
- 10
- Registration Number
- NCT02170532
COPD Assessment and Management Bundle Versus Usual Care
- Conditions
- Interventions
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2019-12-24
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 56
- Registration Number
- NCT01833026
- Locations
- 🇺🇸
University of Illinois, Chicago, Illinois, United States
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 104
- Registration Number
- NCT01312961
- Locations
- 🇺🇸
Investigational Site Number 840003, Minneapolis, Minnesota, United States
🇺🇸Investigational Site Number 840006, Saint Louis, Missouri, United States
🇺🇸Investigational Site Number 840047, Anaheim, California, United States
Effect of Nebulized Bronchodilators on Heart Rate
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2015-10-23
- Lead Sponsor
- Fahim Khorfan, MD
- Target Recruit Count
- 89
- Registration Number
- NCT01151579
- Locations
- 🇺🇸
Genesys Regional Medical Center, Grand Blanc, Michigan, United States
Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
- Conditions
- Interventions
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 30
- Registration Number
- NCT00831376
- Locations
- 🇬🇧
Asthma and Allergy Research Group, Dundee, Angus, United Kingdom
Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
- Conditions
- Interventions
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- University of Dundee
- Registration Number
- NCT00830882
- Locations
- 🇬🇧
Asthma and Allergy Research Group, Dundee, Angus, United Kingdom
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
- Conditions
- Interventions
- First Posted Date
- 2009-01-09
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 2
- Registration Number
- NCT00819637
- Locations
- 🇺🇸
Henry Ford Hospital Emergency Department, Detroit, Michigan, United States
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
- Conditions
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 197
- Registration Number
- NCT00809757
- Locations
- 🇺🇸
Dayton Clinical Research, Dayton, Ohio, United States
🇺🇸ADAC Research, PA, Greenville, South Carolina, United States
🇺🇸Sneeze, Wheeze & Itch Associates LLC, Normal, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.